Chief Financial Officer
Mr. Davis has served as Verrica Pharmaceuticals’ Chief Financial Officer since October 2019. Prior to joining Verrica, he was the Chief Financial Officer of Strongbridge Biopharma, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Previously, he held the title of Senior Vice President and CFO at Tengion, a public, clinical-stage biotechnology company. Mr. Davis also held a similar role at Neose Technologies. He has raised over $500 million in equity financings and over $175 million in debt financings. He has extensive experience in shareholder relations, financial strategy, and SEC accounting, reporting, and compliance. Mr. Davis holds an MBA from The Wharton School, University of Pennsylvania, and a BS in Accounting from Trenton State College.